Kumar A - Search Results

1

Expression of human glandular kallikrein, hK2, in mammalian cells.

Kumar A, Goel AS, Hill TM, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Saedi MS. Kumar A, et al. Cancer Res. 1996 Dec 1;56(23):5397-402. Cancer Res. 1996. PMID: 8968092

2

Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.

Mikolajczyk SD, Millar LS, Marker KM, Grauer LS, Goel A, Cass MM, Kumar A, Saedi MS. Mikolajczyk SD, et al. Among authors: kumar a. Eur J Biochem. 1997 Jun 1;246(2):440-6. doi: 10.1111/j.1432-1033.1997.00440.x. Eur J Biochem. 1997. PMID: 9208936 Free article.

3

Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.

Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Kumar A, et al. Cancer Res. 1997 Aug 1;57(15):3111-4. Cancer Res. 1997. PMID: 9242434

4

Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.

Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Mikolajczyk SD, et al. Among authors: kumar a. Prostate. 1998 Jan 1;34(1):44-50. doi: 10.1002/(sici)1097-0045(19980101)34:1<44::aid-pros6>3.0.co;2-k. Prostate. 1998. PMID: 9428387

5

The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia.

Saedi MS, Hill TM, Kuus-Reichel K, Kumar A, Payne J, Mikolajczyk SD, Wolfert RL, Rittenhouse HG. Saedi MS, et al. Among authors: kumar a. Clin Chem. 1998 Oct;44(10):2115-9. Clin Chem. 1998. PMID: 9761243

6

Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.

Kumar A, Goel AS, Payne JK, Evans C, Mikolajczyk SD, Kuus-Reichel K, Saedi MS. Kumar A, et al. Protein Expr Purif. 1999 Feb;15(1):62-8. doi: 10.1006/prep.1998.0998. Protein Expr Purif. 1999. PMID: 10024471

7

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.

Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Mikolajczyk SD, et al. Among authors: kumar a. Int J Cancer. 1999 May 5;81(3):438-42. doi: 10.1002/(sici)1097-0215(19990505)81:3<438::aid-ijc18>3.0.co;2-u. Int J Cancer. 1999. PMID: 10209959

8

Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.

Kumar A, Mikolajczyk SD, Hill TM, Millar LS, Saedi MS. Kumar A, et al. Prostate. 2000 Aug 1;44(3):248-54. doi: 10.1002/1097-0045(20000801)44:3<248::aid-pros10>3.0.co;2-d. Prostate. 2000. PMID: 10906742

9

A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.

Mikolajczyk SD, Marker KM, Millar LS, Kumar A, Saedi MS, Payne JK, Evans CL, Gasior CL, Linton HJ, Carpenter P, Rittenhouse HG. Mikolajczyk SD, et al. Among authors: kumar a. Cancer Res. 2001 Sep 15;61(18):6958-63. Cancer Res. 2001. PMID: 11559576

10

Long-term culture of primary B cells and in vitro expression of an exogenous gene.

Kumar A, Guido EC, Liu RS, Saedi MS. Kumar A, et al. Immunol Lett. 1995 Sep;47(3):193-7. doi: 10.1016/0165-2478(95)00092-7. Immunol Lett. 1995. PMID: 8747718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,161 results

Search Page

Filters